Quantifi & Deloitte: Introduction to the Impact of XVA on the OTC Markets

Quantifi and Deloitte’s joint seminar ‘The World Post-XVA Implementation’ focussed on the impacts of xVA on OTC markets including the influence on daily business management and how pricing for OTC derivatives has been transformed.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a RiskTech Forum account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: